The U.S. Food and Drug Administration (FDA) has granted fast track designation to MVX-220, Mavrix Bio’s investigational gene therapy for…
Lindsey Shapiro, PhD
Lindsey earned her PhD in neuroscience from Emory University in Atlanta, where she studied novel therapeutic strategies for treatment-resistant forms of epilepsy. She was awarded a fellowship from the American Epilepsy Society in 2019 for this research. Lindsey also previously worked as a postdoctoral researcher, studying the role of inflammation in epilepsy and Alzheimer’s disease.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Lindsey Shapiro, PhD
Sensory problems and other features of autism spectrum disorder (ASD) were prevalent in children with Angelman syndrome and were…
Supporters are gearing up for International Angelman Day (IAD), a community-driven event held every February that aims to raise…
Children with Angelman syndrome have diminished bone health — which continues to decline with age — compared with their…
The translation into other languages of the Global Angelman Syndrome Registry (GASR) website has substantially boosted global participation by…
Emotional and behavioral problems are the symptoms of Angelman syndrome (AS) that most significantly predict lower life quality in…
A device to remotely monitor sleep in Angelman syndrome (AS) patients, called EarlySense, was found to be feasible for…
OV101 (gaboxadol) fails to ease disease severity in children with Angelman syndrome (AS), according to recently published final…
Increases in autophagy, a pathway for clearing cellular waste, were observed in cell and mouse models of Angelman syndrome…
Oxidative stress and mitochondrial dysfunction during early brain development may contribute to symptoms in people with Angelman syndrome (AS),…